---

$0.75

-0.0550 ( -6.87% ) 209.2K

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-04-12	Buy	106383.00	Soffer Rock
2024-04-12	Buy	10638.00	Hashad Mohamed Wa'el Ahmed
2024-04-12	Buy	106383.00	Hare Joshua
2024-03-20	Sale	-80200.00	Hashad Mohamed Wa'el Ahmed
2024-02-02	Sale	-50000.00	Hashad Mohamed Wa'el Ahmed
2024-01-25	Sale	-3074.00	Agafonova Nataliya
2024-01-25	Sale	-5123.00	Hashad Mohamed Wa'el Ahmed
2024-01-25	Sale	-992.00	Lehr Paul T
2024-01-25	Sale	-4098.00	Locklear Lisa
2024-01-11	Buy	5000.00	Ross Cathy